brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]

RxCUI: 1437709
RxNorm name: brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]
Display name: brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]
Full name: brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mirvaso	BRIMONIDINE TARTRATE	Galderma Laboratories, L.P.	f6a4353f-ae69-4214-901f-e5d42a6fbde7	2024-10-24	Warnings, Adverse reactions	Exact identifier rxcui: 1437709

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f6a4353f-ae69-4214-901f-e5d42a6fbde7	brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]	SBD	11	These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996	20241024
f6a4353f-ae69-4214-901f-e5d42a6fbde7	Mirvaso 0.33 % (as brimonidine tartrate 5 mg/ml) Topical Gel	SY	11	These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996	20241024
f6a4353f-ae69-4214-901f-e5d42a6fbde7	Mirvaso 0.33 % Topical Gel	PSN	11	These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996	20241024
f6a4353f-ae69-4214-901f-e5d42a6fbde7	Mirvaso 0.0033 MG/MG Topical Gel	SY	11	These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996	20241024